ConductScience.org, home

Paper36973270

Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.

Jones SE and 1 other. Transl Psychiatry, 2023. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system. Papers, record 36973270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36973270

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system.
PubMed
Journal
Transl Psychiatry
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
2.85
iCite
Revised in PubMed
2023-04-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones SESara E
2Harvey PDPhilip Dhttps://orcid.org/0000-0002-9501-9366

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptor, Muscarinic M4Major topic
Psychotic DisordersMajor topic
Humans
Cognition
Receptor, Muscarinic M1
Cholinergic Agents

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17058341Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.Science1982https://conductscience.org/library/papers/7058341PubMed
219680823Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.J Mol Neurosci2010https://conductscience.org/library/papers/19680823PubMed
37766284Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia.Neuropsychopharmacology1995https://conductscience.org/library/papers/7766284PubMed
415279046The global costs of schizophrenia.Schizophr Bull2004https://conductscience.org/library/papers/15279046PubMed
521704011Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.Am J Pathol2011https://conductscience.org/library/papers/21704011PubMed
610785583Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.Schizophr Res2000https://conductscience.org/library/papers/10785583PubMed
711602695The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11602695PubMed
87909557Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.J Pharmacol Exp Ther1994https://conductscience.org/library/papers/7909557PubMed
932294346A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.N Engl J Med2020https://conductscience.org/library/papers/32294346PubMed
1011423097Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists.Brain Res2001https://conductscience.org/library/papers/11423097PubMed
1123027411Cognitive impairment in schizophrenia.Handb Exp Pharmacol2012https://conductscience.org/library/papers/23027411PubMed
1228887902Atropinic (anticholinergic) burden in antipsychotic-treated patients.Fundam Clin Pharmacol2018https://conductscience.org/library/papers/28887902PubMed
1324442096Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.Neuropsychopharmacology2014https://conductscience.org/library/papers/24442096PubMed
1431749647Domains of cognition and their assessment .Dialogues Clin Neurosci2019https://conductscience.org/library/papers/31749647PubMed
1514702259Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.Am J Psychiatry2004https://conductscience.org/library/papers/14702259PubMed
1625137629Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.ACS Chem Neurosci2014https://conductscience.org/library/papers/25137629PubMed
178915035The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.Dementia1996https://conductscience.org/library/papers/8915035PubMed
1816504943M1 receptors play a central role in modulating AD-like pathology in transgenic mice.Neuron2006https://conductscience.org/library/papers/16504943PubMed
1930170114Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.Neurobiol Dis2019https://conductscience.org/library/papers/30170114PubMed
2036528376Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial.Lancet2022https://conductscience.org/library/papers/36528376PubMed

See all 123 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42529039High perceived energy: exploring distinct patterns of energetic and cognitive functioning in older adults.Front Psychiatry2026https://conductscience.org/library/papers/42529039PubMed
41045433Efficacy and Safety of KarXT (Xanomeline-Trospium; Cobenfy™) in Schizophrenia: A Systematic and Meta-Analysis Review of Randomized Controlled Trials.Psychiatr Q2025https://conductscience.org/library/papers/41045433PubMed
40735384Does Dysregulation Of The Indirect Pathway Contribute To The Pathophysiology Of Catatonia Through Neurotransmitter Imbalance?Clin Neuropsychiatry2025https://conductscience.org/library/papers/40735384PubMed
40671308From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications.CNS Spectr2025https://conductscience.org/library/papers/40671308PubMed
39768939Exploring Cognitive Deficits and Neuromodulation in Schizophrenia: A Narrative Review.Medicina (Kaunas)2024https://conductscience.org/library/papers/39768939PubMed
39199294What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia.Biomolecules2024https://conductscience.org/library/papers/39199294PubMed
38904739Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.Clin Drug Investig2024https://conductscience.org/library/papers/38904739PubMed
36414626Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study.Transl Psychiatry2022https://conductscience.org/library/papers/36414626PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADRA2B151PubTator's text mininghttps://conductscience.org/library/genes/151NCBI Gene
CHRFAM7A89832PubTator's text mininghttps://conductscience.org/library/genes/89832NCBI Gene
DRD21813PubTator's text mininghttps://conductscience.org/library/genes/1813NCBI Gene
ITIH13697PubTator's text mininghttps://conductscience.org/library/genes/3697NCBI Gene
TAAR1134864PubTator's text mininghttps://conductscience.org/library/genes/134864NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36973270

GET https://conductscience.org/api/papers/v1/36973270/references?page=2